Table 2.
Causes of status epilepticus (SE) patients treated with intravenous phenytoin or intravenous sodium valproate as the first-line treatment
| Causes | Phenytoin group N = 37 | Sodium valproate N = 17 | p value |
|---|---|---|---|
| Antiepileptic drug withdrawal |
4 (10.81) |
5 (29.41) |
0.121 |
| Sepsis |
7 (18.92) |
0 |
0.084 |
| Uremia |
0 |
1 (5.88) |
0.315 |
| Cardiac arrest |
5 (13.51) |
2 (11.76) |
1.000 |
| Alcohol withdrawal |
1 (2.70) |
0 |
1.000 |
| CNS infection |
9 (24.32) |
3 (17.65) |
0.584 |
| Head injury |
2 (5.41) |
0 |
1.000 |
| Metabolic causes |
9 (24.32) |
1 (5.88) |
0.105 |
| Others* | 10 (27.03) | 6 (35.29) | 0.537 |
Note. Data presented as median (range) or number (percentage); *phenytoin group: hypoxic encephalopathy 3, CNS vasculitis 2, epidural hematoma 1, postcraniotomy 1, tuberculous encephalitis 1, venous thrombosis 1, ischemic stroke 1; sodium valproate group: postcraniotomy 2, saggital sinus thrombosis 1, subarachnoid hemorrhage 1, intracerebral hemorrhage 1, pregnancy with eclampsia.